Publication Venue For

  • Alzheimer's/Vascular Spectrum Dementia: Classification in Addition to Diagnosis.  73:63-71. 2020
  • Biomarker Localization, Analysis, Visualization, Extraction, and Registration (BLAzER) Methodology for Research and Clinical Brain PET Applications.  70:1241-1257. 2019
  • A Small Molecule Inhibitor of Plasminogen Activator Inhibitor-1 Reduces Brain Amyloid-β Load and Improves Memory in an Animal Model of Alzheimer's Disease.  64:447-457. 2018
  • No effects of black tea on cognitive decline among older US men: A prospective cohort study.  65:99-105. 2018
  • White Matter Degradation is Associated with Reduced Financial Capacity in Mild Cognitive Impairment and Alzheimer's Disease.  60:537-547. 2017
  • N-Terminal Pro-B-Type Natriuretic Peptide and Risk of Future Cognitive Impairment in the REGARDS Cohort.  54:497-503. 2016
  • Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials.  50:1205-1215. 2016
  • Dissociating Statistically-Determined Alzheimer's Disease/Vascular Dementia Neuropsychological Syndromes Using White and Gray Neuroradiological Parameters.  48:833-847. 2015
  • Primary progressive speech abulia.  46:737-745. 2015
  • Noradrenergic sympathetic sprouting and cholinergic reinnervation maintains non-amyloidogenic processing of AβPP.  38:867-879. 2014
  • In vivo and in vitro effects of an apolipoprotein E mimetic peptide on amyloid-β pathology.  36:335-347. 2013
  • Treatment with D3 removes amyloid deposits, reduces inflammation, and improves cognition in aged AβPP/PS1 double transgenic mice.  34:609-620. 2013
  • Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of alzheimer's disease.  30:943-961. 2012
  • Anti-amyloid-β single-chain antibody brain delivery via aav reduces amyloid load but may increase cerebral hemorrhages in an alzheimer's disease mouse model.  27:23-28. 2011
  • Therapeutic potential and anti-amyloidosis mechanisms of tert-butylhydroquinone for Alzheimer's disease.  26:767-778. 2011
  • Transgenic AD model mice, effects of potential anti-AD treatments on inflammation, and pathology.  24:301-313. 2011
  • Lesion-induced hippocampal plasticity in transgenic alzheimer's disease mouse models: Influences of age, genotype, and estrogen.  18:429-445. 2009
  • Distractibility and Alzheimer disease: The "neglected" phenomenon.  15:1-10. 2008